← Back to Cases
PMCPA Case

AUTH/2894/11/16: Director v Mitsubishi Tanabe — Clinical trial disclosure (BindRen) (No breach / Outwith scope)

📅 2016 | 🖉 Dr Anzal Qurbain
📊

Key facts

⌄
Case numberAUTH/2894/11/16
PartiesDirector v Mitsubishi Tanabe
TopicClinical trial disclosure (BindRen)
Complaint received06 December 2016
Completed06 December 2016
OutcomeNo breach; outwith the scope of the Code
Clauses citedNot stated
SanctionsAdditional sanctions: Not stated
Sourcehttps://www.pmcpa.org.uk/cases/completed-cases/auth28941116-director-v-mitsubishi-tanabe

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

⌄
  • A complaint was brought by the Director against Mitsubishi Tanabe.
  • The subject matter related to clinical trial disclosure for BindRen.
  • The case was completed on the same date it was received.
⚖️

Outcome

⌄
  • No breach.
  • Outwith the scope of the Code.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access
← All Cases Book a Free Compliance Call

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training